A consortium of mid-market private equity firms InvAscent and Motilal Oswal PE has bought British PE firm Actis’ entire stake of around 70% in bulk-drugs maker Symbiotec Pharmalab Pvt. Ltd.
— VCCircle
L&L Partners advised
Update 29 May 2019: A Platinum Partners team of
Wadia Ghandy advised
2018-12-18
Deal value: USD 100 million
This deal report is based on a firm's press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.